An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of different resourcing scenarios, the group’s head turned to BTG. We delivered an independent pharmacovigilance organization specialist and former engagement lead in Accenture’s life science practice. She worked with internal executives to evaluate the most efficient model, then develop detailed organization-wide communication and implementation plans.
Find the perfect life science consultant.
Start a ProjectOther content in this Stream
John O'Hara, VP of Strategic Initiatives at Janssen, joins us to discuss J&J's framework for ethical decision-making in pharma manufacturing and supply chain related to the COVID-19 pandemic
The Global Technology Services Group of an F100 pharmaceutical company wanted to streamline global IT application development and turned to Business Talent Group when they needed support managing...
COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.
Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.
Get on-demand talent to help you fuel your critical initiatives, pivot faster, and cover any skills or capacity gaps you may have.
Get on-demand talent to help you fuel your critical initiatives, pivot faster, and cover any skills or capacity gaps you may have.
Speed is key in life science product development. Delays cost, as do mistakes. With independent clinical operations consultants, neither has to be an issue.
A global biopharmaceutical company was preparing to launch a promising new rare disease therapy in the UK and Europe. Concerned that the company’s functional leads were too busy managing existing...
A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next...
Independent life science consultant Kerry Coffee shares best practices for building efficient pharmacovigilance organizations and leveraging AI.
Independent biopharma marketer Kimberly Crichton explains how technology is changing the way life science companies launch products and communicate with consumers and healthcare providers.
Independent talent bring life science companies a unique mix perfectly aligned with the top industry trends of 2020, including real-world experience, strategic rigor, and targeted domain expertise.
Can partnering with start-ups help pharma companies drive healthcare innovation? Digital health expert Karl Hess investigates.
The internal consulting group at a Fortune 200 pharmaceutical company was redesigning the organization’s regulatory submission process—and creating an integrated framework to use for planning all...
Daniel Lee, who created Pfizer's Consulting and Execution Group, or PCE, shares best practices for building a successful internal consulting group.
Life Science project leader Ron Niesen discusses pharma product launch best practices, from gathering data to streamlining decisions.
As life science executives seek new ways to stay competitive in fast-changing markets, they are looking to independents for strategic thought leadership and expertise in specific therapeutic areas
Independent commercial operations expert David Davidovic talks about assessing new technologies, making fast decisions, and building commercial centers of excellence.
John Proietti talks about how to drive change in an organization—and how the health and life sciences industries can capitalize on digital opportunities.